Gilead Sciences Net Income 2006-2020 | GILD

Gilead Sciences annual/quarterly net income history and growth rate from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Gilead Sciences net income for the quarter ending June 30, 2020 was $-3.339B, a 277.61% decline year-over-year.
  • Gilead Sciences net income for the twelve months ending June 30, 2020 was $-0.257B, a 104.32% decline year-over-year.
  • Gilead Sciences annual net income for 2019 was $5.386B, a 1.26% decline from 2018.
  • Gilead Sciences annual net income for 2018 was $5.455B, a 17.87% increase from 2017.
  • Gilead Sciences annual net income for 2017 was $4.628B, a 65.72% decline from 2016.
Gilead Sciences Annual Net Income
(Millions of US $)
2019 $5,386
2018 $5,455
2017 $4,628
2016 $13,501
2015 $18,108
2014 $12,101
2013 $3,075
2012 $2,592
2011 $2,804
2010 $2,901
2009 $2,636
2008 $1,979
2007 $1,585
2006 $-1,190
2005 $814
Gilead Sciences Quarterly Net Income
(Millions of US $)
2020-06-30 $-3,339
2020-03-31 $1,551
2019-12-31 $2,696
2019-09-30 $-1,165
2019-06-30 $1,880
2019-03-31 $1,975
2018-12-31 $3
2018-09-30 $2,097
2018-06-30 $1,817
2018-03-31 $1,538
2017-12-31 $-3,865
2017-09-30 $2,718
2017-06-30 $3,073
2017-03-31 $2,702
2016-12-31 $3,108
2016-09-30 $3,330
2016-06-30 $3,497
2016-03-31 $3,566
2015-12-31 $4,683
2015-09-30 $4,600
2015-06-30 $4,492
2015-03-31 $4,333
2014-12-31 $3,487
2014-09-30 $2,731
2014-06-30 $3,656
2014-03-31 $2,227
2013-12-31 $792
2013-09-30 $789
2013-06-30 $773
2013-03-31 $722
2012-12-31 $763
2012-09-30 $676
2012-06-30 $712
2012-03-31 $442
2011-12-31 $665
2011-09-30 $741
2011-06-30 $746
2011-03-31 $651
2010-12-31 $629
2010-09-30 $705
2010-06-30 $712
2010-03-31 $855
2009-12-31 $802
2009-09-30 $673
2009-06-30 $571
2009-03-31 $589
2008-12-31 $560
2008-09-30 $496
2008-06-30 $435
2008-03-31 $488
2007-12-31 $371
2007-09-30 $398
2007-06-30 $408
2007-03-31 $407
2006-12-31 $-1,666
2006-09-30 $-52
2006-06-30 $265
2006-03-31 $263
2005-12-31 $282
2005-09-30 $179
2005-06-30 $196
2005-03-31 $157
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $77.856B $22.449B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $145.428B 15.80
Bristol Myers Squibb (BMY) United States $135.535B 10.44
CSL (CSLLY) Australia $95.687B 0.00
Vertex Pharmaceuticals (VRTX) United States $70.407B 39.29
Regeneron Pharmaceuticals (REGN) United States $61.028B 23.34
Biogen (BIIB) United States $44.700B 7.65
Illumina (ILMN) United States $44.603B 51.87
Seattle Genetics (SGEN) United States $33.226B 0.00
Moderna (MRNA) United States $27.826B 0.00
BeiGene (BGNE) Cayman Islands $25.444B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.648B 10.27
Genmab (GMAB) Denmark $24.417B 15.43
Genmab (GNMSF) Denmark $23.008B 5.30
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.243B 0.00
Immunomedics (IMMU) United States $19.705B 0.00
Incyte (INCY) United States $19.121B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.817B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.137B 37.76
Exact Sciences (EXAS) United States $15.319B 0.00
BioNTech SE (BNTX) Germany $15.128B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.077B 68.19
BioMarin Pharmaceutical (BMRN) United States $13.783B 100.00
ARGENX SE-ADR (ARGX) Netherlands $12.231B 0.00
QIAGEN (QGEN) Netherlands $11.898B 30.20
Sarepta Therapeutics (SRPT) United States $11.091B 0.00
Guardant Health (GH) United States $11.060B 0.00
Bio-Techne Corp (TECH) United States $9.514B 65.28
Galapagos (GLPG) Belgium $9.249B 33.51
Ascendis Pharma (ASND) Denmark $8.046B 0.00
Repligen (RGEN) United States $7.906B 125.49
Exelixis (EXEL) United States $7.570B 27.53
Mirati Therapeutics (MRTX) United States $7.396B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $7.274B 18.10
MyoKardia (MYOK) United States $7.109B 0.00
Acceleron Pharma (XLRN) United States $6.775B 0.00
Novavax (NVAX) United States $6.615B 0.00
Adaptive Biotechnologies (ADPT) United States $6.524B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.372B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.248B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.964B 184.76
Emergent Biosolutions (EBS) United States $5.522B 21.87
Ultragenyx Pharmaceutical (RARE) United States $5.156B 0.00
Blueprint Medicines (BPMC) United States $5.061B 0.00
Zai Lab (ZLAB) China $4.799B 0.00
Vir Biotechnology (VIR) United States $4.794B 0.00
China Biologic Products (CBPO) China $4.379B 26.00
Arena Pharmaceuticals (ARNA) United States $4.358B 0.00
MorphoSys AG (MOR) Germany $4.195B 54.98
NeoGenomics (NEO) United States $4.072B 1229.00
Legend Biotech (LEGN) United States $3.990B 0.00
Denali Therapeutics (DNLI) United States $3.847B 0.00
Amicus Therapeutics (FOLD) United States $3.644B 0.00
Bluebird Bio (BLUE) United States $3.642B 0.00
Halozyme Therapeutics (HALO) United States $3.633B 0.00
Twist Bioscience (TWST) United States $3.519B 0.00
Fate Therapeutics (FATE) United States $3.422B 0.00
Insmed (INSM) United States $3.324B 0.00
Global Blood Therapeutics (GBT) United States $3.310B 0.00
Reata Pharmaceuticals (RETA) United States $3.185B 0.00
Sorrento Therapeutics (SRNE) United States $2.808B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.793B 0.00
Alkermes (ALKS) Ireland $2.629B 55.10
PHARMA MAR SA (PHMMF) Spain $2.255B 0.00
Mesoblast (MESO) Australia $2.251B 0.00
Seres Therapeutics (MCRB) United States $2.192B 0.00
I-Mab (IMAB) China $2.190B 0.00
Zymeworks (ZYME) Canada $2.057B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.038B 0.00
Eidos Therapeutics (EIDX) United States $1.931B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 21.57
Inovio Pharmaceuticals (INO) United States $1.895B 0.00
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Editas Medicine (EDIT) United States $1.808B 0.00
Intra-Cellular Therapies (ITCI) United States $1.719B 0.00
Revance Therapeutics (RVNC) United States $1.695B 0.00
UniQure (QURE) Netherlands $1.599B 0.00
Cytokineticsorporated (CYTK) United States $1.574B 0.00
Amarin (AMRN) Ireland $1.557B 0.00
Ligand Pharmaceuticals (LGND) United States $1.540B 52.06
Viela Bio (VIE) United States $1.511B 0.00
Zealand Pharma (ZEAL) Denmark $1.475B 0.00
Sangamo Therapeutics (SGMO) United States $1.394B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.378B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.369B 0.00
Coherus BioSciences (CHRS) United States $1.344B 7.84
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Mersana Therapeutics (MRSN) United States $1.285B 0.00
Beam Therapeutics (BEAM) United States $1.279B 0.00
Intellia Therapeutics (NTLA) United States $1.269B 0.00
Epizyme (EPZM) United States $1.221B 0.00
Arcus Biosciences (RCUS) United States $1.130B 0.00
Compugen (CGEN) Israel $1.117B 0.00
NGM Biopharmaceuticals (NGM) United States $1.109B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.055B 0.00
Alcobra (ARCT) United States $1.042B 0.00
REGENXBIO (RGNX) United States $1.042B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.997B 0.00
Castle Biosciences (CSTL) United States $0.995B 0.00
Athenex (ATNX) United States $0.993B 0.00
Myriad Genetics (MYGN) United States $0.952B 0.00
Retrophin (RTRX) United States $0.948B 0.00
Heska (HSKA) United States $0.935B 0.00
Arvinas (ARVN) United States $0.922B 0.00
Genetron Holdings (GTH) China $0.857B 0.00
Alector (ALEC) United States $0.856B 0.00
Adverum Biotechnologies (ADVM) United States $0.843B 0.00
Pliant Therapeutics (PLRX) United States $0.841B 0.00
Morphic Holding (MORF) United States $0.839B 0.00
Vericel (VCEL) United States $0.823B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.807B 0.00
Cellectis S.A (CLLS) France $0.789B 0.00
NantKwest (NK) United States $0.775B 0.00
Agenus (AGEN) United States $0.747B 0.00
Protagonist Therapeutics (PTGX) United States $0.745B 0.00
Codexis (CDXS) United States $0.710B 0.00
Pharming Group (PHGUF) Netherlands $0.704B 16.07
MiMedx (MDXG) United States $0.701B 0.00
VBI Vaccines (VBIV) United States $0.689B 0.00
Frequency Therapeutics (FREQ) United States $0.665B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Kadmon Holdings (KDMN) United States $0.637B 0.00
Northwest Biotherapeutics (NWBO) United States $0.626B 0.00
Intrexon (PGEN) United States $0.610B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Celldex Therapeutics (CLDX) United States $0.594B 0.00
Cara Therapeutics (CARA) United States $0.579B 0.00
Scholar Rock Holding (SRRK) United States $0.552B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.550B 0.00
Forte Biosciences (FBRX) United States $0.550B 0.00
Geron (GERN) United States $0.546B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.540B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.540B 0.00
Clovis Oncology (CLVS) United States $0.524B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.519B 4.55
MeiraGTx Holdings (MGTX) United States $0.495B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.493B 0.00
Albireo Pharma (ALBO) United States $0.489B 0.00
Anika Therapeutics (ANIK) United States $0.486B 21.23
IVERIC Bio (ISEE) United States $0.483B 0.00
Dynavax Technologies (DVAX) United States $0.482B 0.00
Cel-Sci (CVM) United States $0.476B 0.00
Cue Biopharma (CUE) United States $0.454B 0.00
Kala Pharmaceuticals (KALA) United States $0.445B 0.00
Amryt Pharma (AMYT) United Kingdom $0.443B 0.00
MannKind (MNKD) United States $0.438B 0.00
Pfenex (PFNX) United States $0.438B 0.00
Syros Pharmaceuticals (SYRS) United States $0.437B 0.00
Avid Bioservices (CDMO) United States $0.435B 0.00
Starpharma Holdings (SPHRY) Australia $0.427B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.407B 0.00
UROGEN PHARMA (URGN) United States $0.404B 0.00
AnaptysBio (ANAB) United States $0.402B 0.00
Athersys (ATHX) United States $0.401B 0.00
Puma Biotechnology (PBYI) United States $0.399B 0.00
Prothena (PRTA) Ireland $0.396B 0.00
Trevena (TRVN) United States $0.392B 0.00
BioDelivery Sciences (BDSI) United States $0.380B 26.89
PDL BioPharma (PDLI) United States $0.380B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.379B 0.00
Sutro Biopharma (STRO) United States $0.369B 0.00
IBio (IBIO) United States $0.365B 0.00
Kamada (KMDA) Israel $0.357B 17.06
Cellular Biomedicine (CBMG) United States $0.356B 0.00
Merus (MRUS) Netherlands $0.352B 0.00
ANI Pharmaceuticals (ANIP) United States $0.348B 8.21
AC Immune SA (ACIU) Switzerland $0.345B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.344B 0.00
Fortress Biotech (FBIO) United States $0.343B 0.00
WAVE Life Sciences (WVE) Singapore $0.335B 0.00
Precision BioSciences (DTIL) United States $0.333B 0.00
Cardiff Oncology (CRDF) United States $0.325B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.320B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.315B 0.00
CytomX Therapeutics (CTMX) United States $0.309B 0.00
Innate Pharma S.A (IPHA) France $0.304B 0.00
OSMOTICA PHARM (OSMT) United States $0.278B 0.00
Selecta Biosciences (SELB) United States $0.274B 0.00
Affimed (AFMD) Germany $0.261B 0.00
Pluristem Therapeutics (PSTI) Israel $0.259B 0.00
Arbutus Biopharma (ABUS) United States $0.257B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.249B 0.00
Prometic Life Sciences (LMNL) Canada $0.248B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
NextCure (NXTC) United States $0.235B 0.00
Cyclerion Therapeutics (CYCN) United States $0.234B 0.00
TELA Bio (TELA) United States $0.230B 0.00
HOOKIPA Pharma (HOOK) United States $0.211B 0.00
Spero Therapeutics (SPRO) United States $0.210B 0.00
Verastem (VSTM) United States $0.209B 0.00
Dyadic (DYAI) United States $0.207B 0.00
XOMA (XOMA) United States $0.206B 0.00
GENFIT S.A (GNFT) France $0.206B 0.00
ADMA Biologics Inc (ADMA) United States $0.190B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.189B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
DBV Technologies S.A (DBVT) France $0.188B 0.00
Aduro Biotech (ADRO) United States $0.187B 0.00
Liquidia Technologies (LQDA) United States $0.185B 0.00
CorMedix Inc (CRMD) United States $0.184B 0.00
Biofrontera AG (BFRA) Germany $0.179B 0.00
Kindred Biosciences (KIN) United States $0.173B 0.00
Theratechnologies (THTX) Canada $0.170B 0.00
Cerecor (CERC) United States $0.170B 0.00
Five Prime Therapeutics (FPRX) United States $0.168B 0.00
Checkpoint Therapeutics (CKPT) United States $0.168B 0.00
Eton Pharmaceuticals (ETON) United States $0.164B 0.00
SESEN BIO, INC (SESN) United States $0.159B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.156B 7.30
Aptinyx (APTX) United States $0.155B 0.00
VolitionRX (VNRX) United States $0.155B 0.00
Exicure (XCUR) United States $0.152B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.149B 0.00
Nicox SA (NICXF) France $0.149B 0.00
AquaBounty Technologies (AQB) United States $0.146B 0.00
Aytu Bioscience (AYTU) United States $0.145B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.141B 0.00
Celyad SA (CYAD) Belgium $0.138B 0.00
Bellus Health (BLU) Canada $0.133B 0.00
Applied Genetic Technologies (AGTC) United States $0.129B 0.00
VTv Therapeutics (VTVT) United States $0.128B 0.00
Protalix BioTherapeutics (PLX) Israel $0.127B 0.00
Cidara Therapeutics (CDTX) United States $0.126B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.117B 0.00
Lumos Pharma (LUMO) United States $0.116B 0.00
Strongbridge Biopharma (SBBP) United States $0.115B 0.00
Palatin Technologies (PTN) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.110B 5.60
Pieris Pharmaceuticals (PIRS) United States $0.108B 0.00
Evogene (EVGN) Israel $0.105B 0.00
Windtree Therapeutics (WINT) United States $0.104B 0.00
PHASEBIO PHARMA (PHAS) United States $0.102B 0.00
Gritstone Oncology (GRTS) United States $0.100B 0.00
Enzo Biochem (ENZ) United States $0.100B 0.00
Antibe Therapeutics (ATBPF) Canada $0.098B 0.00
Catalyst Biosciences (CBIO) United States $0.096B 0.00
Unum Therapeutics (UMRX) United States $0.096B 0.00
Abeona Therapeutics (ABEO) United States $0.094B 0.00
AIT Therapeutics (XAIR) United States $0.090B 0.00
Oncobiologics (OTLK) United States $0.085B 0.00
Bionano Genomics (BNGO) United States $0.083B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
Idera Pharmaceuticals (IDRA) United States $0.078B 0.00
ARAVIVE, INC (ARAV) United States $0.078B 0.00
Edesa Biotech (EDSA) Canada $0.077B 0.00
DiaMedica Therapeutics (DMAC) United States $0.076B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Clearside Biomedical (CLSD) United States $0.069B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.067B 0.00
Adocia (ADOCY) France $0.067B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.062B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.061B 0.00
Appili Therapeutics (APLIF) Canada $0.060B 0.00
TRACON Pharmaceuticals (TCON) United States $0.059B 0.00
Proteostasis Therapeutics (PTI) United States $0.058B 0.00
Curis (CRIS) United States $0.056B 0.00
AmpliPhi Biosciences (ARMP) United States $0.056B 0.00
Soligenix (SNGX) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Novogen (KZIA) Australia $0.049B 0.00
Cocrystal Pharma (COCP) United States $0.048B 0.00
CollPlant Holdings (CLGN) Israel $0.048B 0.00
Organovo Holdings (ONVO) United States $0.048B 0.00
Stealth BioTherapeutics (MITO) United States $0.047B 67.50
Genetic Technologies (GENE) Australia $0.046B 0.00
Apricus Biosciences (SEEL) United States $0.046B 0.00
Signal Genetics (MGEN) United States $0.045B 0.00
AnPac Bio-Medical Science (ANPC) China $0.044B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Pulmatrix (PULM) United States $0.041B 0.00
Vaccinex (VCNX) United States $0.036B 0.00
Chanticleer Holdings (SONN) United States $0.034B 0.00
ATyr Pharma (LIFE) United States $0.031B 0.00
Prana Biotechnology (ATHE) Australia $0.031B 0.00
OvaScience (MLND) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Advaxis (ADXS) United States $0.028B 0.00
Acorda Therapeutics (ACOR) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Celsion (CLSN) United States $0.024B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.024B 0.00
Spherix (AIKI) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Cesca Therapeutics (THMO) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
MYOS RENS Technology (MYOS) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00